BIMI (BIMI) Stock Price, News & Analysis

Company Overview

BIMI International Medical Exchange Ltd. is a China-based company specializing in the distribution and marketing of advanced medical imaging equipment, in vitro diagnostic reagents and nuclear medicine products. Through its network of warehouses and sales offices in key metropolitan areas, the company supplies hospitals, clinics and diagnostic laboratories with a broad range of imported instruments and consumables. Its product portfolio spans CT, MRI and ultrasound systems as well as reagents for immunoassays, molecular diagnostics and radiopharmaceuticals used in oncology and cardiology.

Founded in 1995 and headquartered in Beijing, BIMI has built strategic partnerships with global manufacturers in Europe, North America and Japan. These alliances enable BIMI to introduce cutting-edge technologies—such as digital PET/CT scanners and next-generation sequencing platforms—into the Chinese market. The company also provides value-added services, including equipment installation, calibration, preventive maintenance and training programs for clinical personnel to ensure seamless integration of new technologies into hospital workflows.

Over the years, BIMI has expanded its geographic footprint beyond mainland China, establishing representative offices in Hong Kong, South Korea and select Southeast Asian markets. This regional presence supports the company’s objective to become a leading medical technology distributor in the Asia-Pacific region. In addition to commercial operations, BIMI pursues collaboration agreements with local research institutions and academic hospitals to facilitate clinical trials and post-market studies of novel diagnostic agents.

Under the leadership of Dr. Jie Zhang, the company’s founder and Chief Executive Officer, BIMI has emphasized innovation, regulatory compliance and customer service excellence. The senior management team includes seasoned executives with backgrounds in medical affairs, supply-chain management and healthcare consulting. Moving forward, BIMI aims to broaden its product offerings in personalized medicine and digital health, reinforcing its role as a key conduit for advanced medical solutions in fast-growing healthcare markets.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $1.65
• Volume: 1,064 shs
• Average Volume: 2,856 shs
• Market Capitalization: $394.06 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIMI Stock Analysis - Frequently Asked Questions

When did BIMI's stock split?

Shares of BIMI reverse split on Monday, December 12th 2022.The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of BIMI?

Shares of BIMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BIMI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIMI investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:BIMI
• CIK: 1213660
• Web: www.bimihc.com
• Phone: (212) 542-0028
• Fax: 86-24-8563-1159
• Employees: 520
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $12.63 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,590,000
• Free Float: 3,591,000
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: -0.74